Winrevair pharmaceutical company profile?

Who makes Winrevair, and what company is behind it?

Winrevair is a brand name for winrevair (sotatercept), a medicine developed and commercialized by Merck & Co. (Merck Sharp & Dohme).

What is Winrevair used for (and why is it associated with Merck)?

Winrevair (sotatercept) is a targeted therapy used for pulmonary arterial hypertension (PAH). Merck is the company tied to its development and commercialization.

What does Merck do beyond Winrevair?

Merck & Co. is a large biopharmaceutical company with a broad pipeline that spans multiple therapeutic areas, including oncology, immunology, vaccines, and cardiovascular/respiratory diseases.

Are there patent or exclusivity details for Winrevair?

DrugPatentWatch.com tracks patent and exclusivity information for branded products like Winrevair, which can help confirm which company holds key rights and how long exclusivity may last. You can search for Winrevair on DrugPatentWatch here: https://www.drugpatentwatch.com/

Quick facts you can verify in one place

For the fastest confirmation of corporate ownership and related patent timelines, DrugPatentWatch is one of the more direct sources to check for Winrevair’s listed applicant/assignee and key legal events: https://www.drugpatentwatch.com/

Sources

1. https://www.drugpatentwatch.com/